🔗 Share this article

Chancellor Rachel Reeves has stated she is preparing "targeted measures to deal with cost of living issues" in the upcoming financial statement.

Speaking to the BBC, she emphasized that lowering inflation is a shared task of both the government and the central bank.

The United Kingdom's inflation rate is forecast to be the most elevated among the G7 industrialized countries this calendar year and next.

Potential Energy Bill Interventions

Sources suggest the government could take action to lower energy bills, for example by slashing the current 5% rate of value-added tax applied on energy supplies.

An additional option is to reduce some of the government charges presently added to household expenses.

Fiscal Limitations and Expert Predictions

The administration will obtain the next report from the independent fiscal watchdog, the OBR, on Monday, which will show how much scope there is for such actions.

The view from the majority of economists is that Reeves will have to introduce tax rises or expenditure reductions in order to adhere to her self-imposed borrowing rules.

Earlier on the same day, analysis suggested there was a twenty-two billion pound shortfall for the Treasury chief to resolve, which is at the more modest range of projections.

"It is a joint responsibility between the Bank of England and the government to bear down further on some of the drivers of price increases," the Chancellor told the BBC in the US capital, at the conferences of the IMF and global financial institution.

Revenue Commitments and Global Issues

While much of the attention has been on likely tax rises, the chancellor said the latest information from the fiscal watchdog had not altered her commitment to election pledges not to increase rates on earnings tax, sales tax or National Insurance.

She blamed an "uncertain world" with growing geopolitical and trade tensions for the fiscal revenue measures, likely to be directed on those "with the broadest shoulders."

International Economic Tensions

Commenting on apprehensions about the United Kingdom's economic relations with the Asian nation she said: "The UK's security interests always take priority."

Recent announcement by China to tighten export controls on rare earths and other materials that are essential for advanced tech production led US President the US President to threaten an extra 100% tariff on imports from the Asian country, raising the risk of an full-scale commercial conflict between the two largest economies.

The American finance chief labeled the Chinese action "commercial pressure" and "a international production power grab."

Inquired about considering the American proposal to participate in its dispute with China, the Chancellor said she was "very concerned" by China's actions and encouraged the Beijing authorities "to avoid restrictions and limit trade."

She said the decision was "damaging for the international commerce and generates further obstacles."

"It is my opinion there are sectors where we should address China, but there are also valuable opportunities to trade with China's economy, including banking sector and other areas of the economic system. We've got to get that balance correct."

The Treasury chief also confirmed she was working with G7 counterparts "regarding our own essential resources approach, so that we are reduced dependence."

Health Service Drug Pricing and Funding

The Chancellor also recognized that the cost the NHS spends on pharmaceuticals could go up as a consequence of ongoing negotiations with the Trump administration and its drugs companies, in return for lower tariffs and capital.

Some of the world's largest pharmaceutical manufacturers have said lately that they are either pausing or abandoning operations in the UK, with several attributing the low prices they are getting.

Recently, the government science advisor said the price the NHS spends on drugs would must go up to halt firms and pharmaceutical investment leaving the United Kingdom.

The Chancellor informed the BBC: "It has been observed due to the pricing regime, that drug testing, new drugs have not been provided in the United Kingdom in the way that they are in other continental states."

"We want to guarantee that people receiving treatment from the National Health Service are can receive the finest critical treatments in the globe. And so we are examining this situation, and... aiming to obtain more funding into the UK."